ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 875,09
-0,40%
Dow Jones
44 556,04
0,30%
DAX
21 414,44
-0,45%
Brent Oil
75,67
-0,36%
Bitcoin
97 482,48
-0,39%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. GeoVax Labs Inc (GOVX) Cours

GeoVax Labs Inc

GeoVax Labs Inc (GOVX)

NASDAQ
1,74
-0,03
(-1,69%)
Fermé 05 Février 10:00PM
Retardé de 15 minutes
1,74
0,00
( 0,00% )
Avant marché: 10:33AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
1,74
Prix Achat
1,70
Prix Vente
1,90
Volume échangé
-
0,00 Fourchette du Jour 0,00
1,0901 Plage de 52 semaines 11,18
Cap du marché
16,419M
Clôture Veille
1,74
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
812 941
Actions en circulation
9 436 069
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,63
Bénéfice par action (BPA)
-2,75
Chiffre d'affairess
-
Bénéfice net
-25,97M

À propos de GeoVax Labs Inc

Geovax Labs Inc is us-based clinical-stage biotechnology company. Geovax Labs Inc is us-based clinical-stage biotechnology company.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.geovax.com
Siège social
Wilmington, Delaware, USA
Fondé
-
GeoVax Labs Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker GOVX. Le dernier cours de clôture d'GeoVax Labs était de US$1,74. Au cours de la dernière année, les actions de GeoVax Labs ont été négociées dans une fourchette de prix de US$ 1,0901 à US$ 11,18.

GeoVax Labs compte actuellement 9 436 069 actions en circulation. La capitalisation boursière d'GeoVax Labs est de US$16,42 million. GeoVax Labs a un ratio cours/bénéfice (ratio PE) de -0.63.

GOVX Dernières nouvelles

Plus de nouvelles

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Adds to Growing Portfolio of Intellectual Property Assets ATLANTA, Ga., Dec. 09, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies...

09 Décembre 2024
GlobeNewswire Inc.

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that...

26 Novembre 2024
GlobeNewswire Inc.

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

GEO-CM04S1 Improved Immune Response vs mRNA Vaccine ATLANTA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and...

19 Novembre 2024
GlobeNewswire Inc.

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Progress in GEO-CM04S1 BARDA/Project NextGen Phase 2b trial; multiple data readouts of existing COVID-19 vaccine Phase 2 trials expected during fourth quarter 2024 Gedeptin® on track to advance...

12 Novembre 2024
GlobeNewswire Inc.

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GeoVax to Host Conference Call at 4:30 PM ET ATLANTA, Nov. 05, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against...

05 Novembre 2024
GlobeNewswire Inc.

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

ATLANTA, Ga., Oct. 02, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced...

02 Octobre 2024
GlobeNewswire Inc.

GeoVax to Participate in Upcoming Investor Conferences in September

ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...

03 Septembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

30 Août 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

30 Août 2024
Edgar (US Regulatory)

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...

29 Août 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.22-11.22448979591.962.071.76488861.79120571CS
4-0.62-26.27118644072.362.381.75583092.00796778CS
12-0.9-34.09090909092.643.151.78129412.47645868CS
260.021.162790697671.7211.181.631555815.19498927CS
52-1.17-40.2061855672.9111.181.090122940114.48165178CS
156-32.31-94.889867841434.0564.51.0901375174725.21721525CS
260-43.26-96.133333333345130.651.0901300263232.254822CS

GOVX - Frequently Asked Questions (FAQ)

What is the current GeoVax Labs share price?
The current share price of GeoVax Labs is US$ 1,74
How many GeoVax Labs shares are in issue?
GeoVax Labs has 9 436 069 shares in issue
What is the market cap of GeoVax Labs?
The market capitalisation of GeoVax Labs is USD 16,42M
What is the 1 year trading range for GeoVax Labs share price?
GeoVax Labs has traded in the range of US$ 1,0901 to US$ 11,18 during the past year
What is the PE ratio of GeoVax Labs?
The price to earnings ratio of GeoVax Labs is -0,63
What is the reporting currency for GeoVax Labs?
GeoVax Labs reports financial results in USD
What is the latest annual profit for GeoVax Labs?
The latest annual profit of GeoVax Labs is USD -25,97M
What is the registered address of GeoVax Labs?
The registered address for GeoVax Labs is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the GeoVax Labs website address?
The website address for GeoVax Labs is www.geovax.com
Which industry sector does GeoVax Labs operate in?
GeoVax Labs operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
OPOFOld Point Financial Corporation
US$ 39,51
(58,99%)
4
TWINTwin Disc Inc
US$ 17,88
(58,93%)
27
IBACIB Acquisition Corporation
US$ 16,24
(58,90%)
2
ADSEADD TEC Energy PLC
US$ 23,39
(56,66%)
12
AFRIForafric Global PLC
US$ 14,99
(56,15%)
19
SBFGSB Finanical Group Inc
US$ 12,22
(-46,85%)
10
THRYThryv Holdings Inc
US$ 10,01
(-46,01%)
4
IROQIF Bancorp Inc
US$ 15,00
(-38,17%)
200
AURAAura Biosciences Inc
US$ 5,01
(-37,38%)
1
WMPNWilliam Penn Bancorporation
US$ 8,00
(-35,22%)
201
CYNCYNGN Inc
US$ 0,0793
(11,69%)
12,52M
SXTP60 Degrees Pharmaceuticals Inc
US$ 0,8758
(46,70%)
9,63M
UPCUniverse Pharmaceuticals Inc
US$ 0,325
(20,41%)
5,51M
SFHGSamfine Creation Holdings Group Ltd
US$ 1,50
(50,00%)
5,01M
RIMEAlgorhythm Holdings Inc
US$ 0,026
(6,56%)
4,26M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
GOVX
GeoVax Labs
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces